P

PerkinElmer Inc
LSE:0KHE

Watchlist Manager
PerkinElmer Inc
LSE:0KHE
Watchlist
Price: 110.62 USD -0.56%
Market Cap: 1.2T USD
Have any thoughts about
PerkinElmer Inc?
Write Note

PerkinElmer Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

PerkinElmer Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
P
PerkinElmer Inc
LSE:0KHE
Cash & Cash Equivalents
$1.2B
CAGR 3-Years
36%
CAGR 5-Years
26%
CAGR 10-Years
20%
Thermo Fisher Scientific Inc
NYSE:TMO
Cash & Cash Equivalents
$4.6B
CAGR 3-Years
-27%
CAGR 5-Years
30%
CAGR 10-Years
24%
Danaher Corp
NYSE:DHR
Cash & Cash Equivalents
$2.6B
CAGR 3-Years
1%
CAGR 5-Years
-29%
CAGR 10-Years
-4%
Mettler-Toledo International Inc
NYSE:MTD
Cash & Cash Equivalents
$71.6m
CAGR 3-Years
-27%
CAGR 5-Years
-10%
CAGR 10-Years
-6%
Agilent Technologies Inc
NYSE:A
Cash & Cash Equivalents
$1.3B
CAGR 3-Years
-4%
CAGR 5-Years
-1%
CAGR 10-Years
-5%
IQVIA Holdings Inc
NYSE:IQV
Cash & Cash Equivalents
$1.6B
CAGR 3-Years
2%
CAGR 5-Years
13%
CAGR 10-Years
9%
No Stocks Found

PerkinElmer Inc
Glance View

Market Cap
1.2T USD
Industry
Life Sciences Tools & Services
Economic Moat
None

PerkinElmer Inc., originally founded in 1937, has evolved over the decades into a leading global innovator in the field of healthcare and life sciences. It began its journey by focusing on precision optics, but with time, the company strategically pivoted towards life sciences, diagnostics, and applied markets. This transformation harnessed its focus on innovative technologies that aid in the process of scientific discovery and clinical diagnostics. PerkinElmer primarily thrives on providing advanced solutions for detecting and analyzing biological and chemical compounds. With its robust portfolio of products and services, the company empowers laboratories and research institutions worldwide to unlock new insights into areas such as genetics, oncology, and environmental health. The company's revenue streams are multifaceted, embodying a mix of instruments, software, and services that cater to a variety of needs in the scientific and healthcare communities. PerkinElmer’s business model is anchored on selling sophisticated laboratory equipment like mass spectrometers, imaging systems, and diagnostic testing kits. Beyond equipment sales, the company also capitalizes on recurring revenue from consumables and services, ensuring a steady cash flow that supports its ongoing R&D efforts and market expansion initiatives. Furthermore, with a strategic emphasis on bolstering partnerships and acquisitions, PerkinElmer continually enhances its capability to deliver comprehensive solutions, thus maintaining its competitive edge in the ever-evolving scientific landscape. Through this, it manages to contribute not just to profitability but to a broader mission of improving global health outcomes.

0KHE Intrinsic Value
1.63 USD
Overvaluation 99%
Intrinsic Value
Price
P

See Also

What is PerkinElmer Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.2B USD

Based on the financial report for Sep 29, 2024, PerkinElmer Inc's Cash & Cash Equivalents amounts to 1.2B USD.

What is PerkinElmer Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
20%

Over the last year, the Cash & Cash Equivalents growth was 8%. The average annual Cash & Cash Equivalents growth rates for PerkinElmer Inc have been 36% over the past three years , 26% over the past five years , and 20% over the past ten years .

Back to Top